|
|
|
|
|
by vikramkr
2142 days ago
|
|
This has been considered as a potential factor in explaining the variability in COVID outcomes for a while, both in the sense that prior infection with a cold virus could help protect from COVID through T cell responses and could make COVID worse through antibody responses. Cytotoxic T cell responses are definitely good, and it's also good to know that coronaviruses can induce these sorts of long term immunities (so a low antibody response doesn't automatically mean you're susceptible to reinfection). The COVID vaccines in development are also generally trying to induce T cell responses, and knowing that coronavirus epitopes can do that is a really helpful data point in determining the feasibility of that goal. |
|
This hypothesis is entirely untested as far as I know.